{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:18:37Z","timestamp":1770722317244,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Bethune Charitable Foundation","award":["GDZL040"],"award-info":[{"award-number":["GDZL040"]}]},{"name":"Scientific research promotion program for clinical medicine","award":["2025CMFA08"],"award-info":[{"award-number":["2025CMFA08"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["3332024119"],"award-info":[{"award-number":["3332024119"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04598-0","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T03:03:58Z","timestamp":1767755038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, responses to therapy and prognosis of 107 patients with IgG4-related cholangitis: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jia","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-0793","authenticated-orcid":false,"given":"Bing-Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"3","key":"4598_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-021-00529-y","volume":"19","author":"JM L\u00f6hr","year":"2022","unstructured":"L\u00f6hr JM, Vujasinovic M, Rosendahl J, Stone JH, Beuers U. IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol. 2022;19(3):185\u201397.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"4598_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/01.pas.0000136449.37936.6c","volume":"28","author":"Y Zen","year":"2004","unstructured":"Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28(9):1193\u2013203.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4598_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.21685","volume":"45","author":"E Bj\u00f6rnsson","year":"2007","unstructured":"Bj\u00f6rnsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology. 2007;45(6):1547\u201354.","journal-title":"Hepatology"},{"issue":"6","key":"4598_CR4","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jhep.2023.08.005","volume":"79","author":"R Kersten","year":"2023","unstructured":"Kersten R, Trampert DC, Herta T, et al. IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies. J Hepatol. 2023;79(6):1502\u201323.","journal-title":"J Hepatol"},{"issue":"1","key":"4598_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14397595.2019.1621000","volume":"30","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa Y, Terao C. Genetic analysis of IgG4-related disease. Mod Rheumatol. 2020;30(1):17\u201323.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"4598_CR6","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","volume":"1","author":"C Terao","year":"2019","unstructured":"Terao C, Ota M, Iwasaki T, et al. IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol. 2019;1(1):e14\u201322.","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"4598_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/gutjnl-2017-314548","volume":"67","author":"LM Hubers","year":"2018","unstructured":"Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018;67(4):728\u201335.","journal-title":"Gut"},{"key":"4598_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)00525-1","volume":"78","author":"D Trampert","year":"2023","unstructured":"Trampert D, Kersten R, Jongejan A, Tolenaars D, van de Graaf S, Beuers U. Laminin 511\u2013E8 is an autoantigen in IgG4-related cholangitis patients that protects cholangiocytes against T lymphocyte-induced epithelial barrier dysfunction. J Hepatol. 2023;78:S60.","journal-title":"J Hepatol"},{"key":"4598_CR9","first-page":"9312142","volume":"2017","author":"A Salah","year":"2017","unstructured":"Salah A, Yoshifuji H, Ito S, et al. High expression of galectin-3 in patients with IgG4-related disease: a proteomic approach. Patholog Res Int. 2017;2017:9312142.","journal-title":"Patholog Res Int"},{"issue":"6","key":"4598_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.bbamcr.2011.01.033","volume":"1813","author":"AL Theiss","year":"2011","unstructured":"Theiss AL, Sitaraman SV. The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta. 2011;1813(6):1137\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"4598_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100385","volume":"3","author":"LM Hubers","year":"2021","unstructured":"Hubers LM, Schuurman AR, Buijs J, et al. Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas. JHEP Rep. 2021;3(6):100385.","journal-title":"JHEP Rep"},{"issue":"11","key":"4598_CR12","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1093\/rheumatology\/keab172","volume":"60","author":"R Wallwork","year":"2021","unstructured":"Wallwork R, Perugino CA, Fu X, et al. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021;60(11):5310\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4598_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jhbp.793","volume":"27","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Mori M, Kubota K, et al. Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2020;27(9):598\u2013603.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"Suppl 18","key":"4598_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","volume":"42","author":"ST Chari","year":"2007","unstructured":"Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic\u2019s HISORt criteria. J Gastroenterol. 2007;42(Suppl 18):39\u201341.","journal-title":"J Gastroenterol"},{"issue":"3","key":"4598_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","volume":"31","author":"H Umehara","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529\u201333.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"4598_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.mpa.0000202941.85955.07","volume":"32","author":"T Nakazawa","year":"2006","unstructured":"Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32(2):229.","journal-title":"Pancreas"},{"issue":"2","key":"4598_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023;77(2):659\u2013702.","journal-title":"Hepatology"},{"issue":"15","key":"4598_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680.","journal-title":"Medicine (Baltimore)"},{"key":"4598_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","volume":"73","author":"G Katz","year":"2022","unstructured":"Katz G, Stone JH. Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med. 2022;73:545\u201362.","journal-title":"Annu Rev Med"},{"issue":"6","key":"4598_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.anai.2020.03.024","volume":"124","author":"E Della-Torre","year":"2020","unstructured":"Della-Torre E, German\u00f2 T, Ramirez GA, Dagna L, Yacoub MR. IgG4-related disease and allergen-specific immunotherapy. Ann Allergy Asthma Immunol. 2020;124(6):631\u20133.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"4598_CR21","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45(6):1538\u201346.","journal-title":"Hepatology"},{"issue":"5","key":"4598_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, Li B, Li Y, et al. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut. 2022;71(5):899\u2013909.","journal-title":"Gut"},{"issue":"4","key":"4598_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2009.200972","volume":"59","author":"R Akitake","year":"2010","unstructured":"Akitake R, Watanabe T, Zaima C, et al. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut. 2010;59(4):542\u20135.","journal-title":"Gut"},{"issue":"12","key":"4598_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/intimm\/dxz050","volume":"31","author":"K Kamata","year":"2019","unstructured":"Kamata K, Watanabe T, Minaga K, et al. Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells. Int Immunol. 2019;31(12):795\u2013809.","journal-title":"Int Immunol"},{"issue":"11","key":"4598_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/MEG.0b013e3282f82970","volume":"20","author":"K Ueno","year":"2008","unstructured":"Ueno K, Watanabe T, Kawata Y, et al. IgG4-related autoimmune pancreatitis involving the colonic mucosa. Eur J Gastroenterol Hepatol. 2008;20(11):1118\u201321.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"4598_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s10620-005-2703-9","volume":"50","author":"K Komatsu","year":"2005","unstructured":"Komatsu K, Hamano H, Ochi Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005;50(6):1052\u20137.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"4598_CR27","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016;68(9):2283\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4598_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jgh.16066","volume":"38","author":"K Kubota","year":"2023","unstructured":"Kubota K, Kamisawa T, Nakazawa T, et al. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: based on a Japanese nationwide study. J Gastroenterol Hepatol. 2023;38(4):556\u201364.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4598_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/MCG.0000000000000509","volume":"50","author":"S Du","year":"2016","unstructured":"Du S, Liu G, Cheng X, et al. Differential diagnosis of immunoglobulin G4-associated cholangitis from cholangiocarcinoma. J Clin Gastroenterol. 2016;50(6):501\u20135.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"4598_CR30","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1007\/s00261-015-0543-4","volume":"40","author":"CS Gardner","year":"2015","unstructured":"Gardner CS, Bashir MR, Marin D, Nelson RC, Choudhury KR, Ho LM. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. Abdom Imaging. 2015;40(8):3052\u201361.","journal-title":"Abdom Imaging"},{"issue":"1","key":"4598_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","volume":"47","author":"T Nakazawa","year":"2012","unstructured":"Nakazawa T, Naitoh I, Hayashi K, et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol. 2012;47(1):79\u201387.","journal-title":"J Gastroenterol"},{"issue":"4","key":"4598_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jgh.16136","volume":"38","author":"SH Cho","year":"2023","unstructured":"Cho SH, Song TJ, Park JS, et al. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: a multicenter cohort study. J Gastroenterol Hepatol. 2023;38(4):648\u201355.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"4598_CR33","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/MPA.0000000000000206","volume":"43","author":"K Hirano","year":"2014","unstructured":"Hirano K, Tada M, Isayama H, Koike K. Intrapancreatic biliary stricture in autoimmune pancreatitis should not be included in IgG4-related sclerosing cholangitis. Pancreas. 2014;43(7):1123.","journal-title":"Pancreas"},{"issue":"1","key":"4598_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gie.2009.08.008","volume":"71","author":"K Hirano","year":"2010","unstructured":"Hirano K, Tada M, Isayama H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010;71(1):85\u201390.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"4598_CR35","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3748\/wjg.v21.i4.1334","volume":"21","author":"T Nakazawa","year":"2015","unstructured":"Nakazawa T, Ikeda Y, Kawaguchi Y, et al. Isolated intrapancreatic IgG4-related sclerosing cholangitis. World J Gastroenterol. 2015;21(4):1334\u201343.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"4598_CR36","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00535-009-0108-9","volume":"44","author":"I Naitoh","year":"2009","unstructured":"Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009;44(11):1147\u201355.","journal-title":"J Gastroenterol"},{"issue":"6","key":"4598_CR37","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00261-019-01944-1","volume":"44","author":"J Swensson","year":"2019","unstructured":"Swensson J, Tirkes T, Tann M, Cui E, Sandrasegaran K. Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center. Abdom Radiol (NY). 2019;44(6):2111\u20135.","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"4598_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/0284185113481018","volume":"54","author":"JH Kim","year":"2013","unstructured":"Kim JH, Byun JH, Kim SY, et al. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol. 2013;54(6):601\u20137.","journal-title":"Acta Radiol"},{"issue":"3","key":"4598_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5009\/gnl18085","volume":"13","author":"A Tanaka","year":"2019","unstructured":"Tanaka A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut Liver. 2019;13(3):300\u20137.","journal-title":"Gut Liver"},{"issue":"1","key":"4598_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jhbp.596","volume":"26","author":"T Kamisawa","year":"2019","unstructured":"Kamisawa T, Nakazawa T, Tazuma S, et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2019;26(1):9\u201342.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"4598_CR41","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.26977","volume":"59","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014;59(5):1954\u201363.","journal-title":"Hepatology"},{"issue":"2","key":"4598_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00365521.2017.1416159","volume":"53","author":"L Tan","year":"2018","unstructured":"Tan L, Guan X, Zeng T, et al. The significance of serum IgG(4) and CA19-9, autoantibodies in diagnosis and differential diagnosis of IgG(4)-related sclerosing cholangitis. Scand J Gastroenterol. 2018;53(2):206\u201311.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"4598_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","volume":"10","author":"XL Qin","year":"2004","unstructured":"Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol. 2004;10(3):427\u201332.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4598_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/gutjnl-2018-317934","volume":"69","author":"Y Kato","year":"2020","unstructured":"Kato Y, Azuma K, Someda H, Shiokawa M, Chiba T. Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511\u2013E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis. Gut. 2020;69(3):607\u20139.","journal-title":"Gut"},{"issue":"9","key":"4598_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392.","journal-title":"Mod Pathol"},{"issue":"4","key":"4598_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.semdp.2012.07.005","volume":"29","author":"Y Zen","year":"2012","unstructured":"Zen Y, Nakanuma Y, Portmann B. Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin Diagn Pathol. 2012;29(4):205\u201311.","journal-title":"Semin Diagn Pathol"},{"issue":"12","key":"4598_CR47","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","volume":"34","author":"Y Zen","year":"2010","unstructured":"Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"4598_CR48","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/j.1440-1746.2010.06346.x","volume":"25","author":"H Kawakami","year":"2010","unstructured":"Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater\u2019s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25(10):1648\u201355.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4598_CR49","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gie.2009.12.004","volume":"71","author":"SH Moon","year":"2010","unstructured":"Moon SH, Kim MH, Park DH, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71(6):960\u20136.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"4598_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"EASL Clinical Practice Guidelines on sclerosing cholangitis","year":"2022","unstructured":"EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77(3):761\u2013806.","journal-title":"J Hepatol"},{"issue":"3","key":"4598_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103273","volume":"22","author":"O Orozco-G\u00e1lvez","year":"2023","unstructured":"Orozco-G\u00e1lvez O, Fern\u00e1ndez-Codina A, Lanzillotta M, et al. Development of an algorithm for IgG4-related disease management. Autoimmun Rev. 2023;22(3):103273.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4598_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00535-016-1163-7","volume":"51","author":"Y Zen","year":"2016","unstructured":"Zen Y, Kawakami H, Kim JH. IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol. 2016;51(4):295\u2013312.","journal-title":"J Gastroenterol"},{"issue":"4","key":"4598_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/rheumatology\/kez380","volume":"59","author":"D Omar","year":"2020","unstructured":"Omar D, Chen Y, Cong Y, Dong L. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis. Rheumatology (Oxford). 2020;59(4):718\u201326.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4598_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","volume":"66","author":"A Masamune","year":"2017","unstructured":"Masamune A, Nishimori I, Kikuta K, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66(3):487\u201394.","journal-title":"Gut"},{"issue":"12","key":"4598_CR55","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1136\/gut.2006.115246","volume":"56","author":"K Hirano","year":"2007","unstructured":"Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56(12):1719\u201324.","journal-title":"Gut"},{"issue":"3","key":"4598_CR56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134(3):706\u201315.","journal-title":"Gastroenterology"},{"issue":"6","key":"4598_CR57","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cgh.2016.12.038","volume":"15","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Tazuma S, Okazaki K, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15(6):920-6.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4598_CR58","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jhbp.957","volume":"28","author":"Y Kurita","year":"2021","unstructured":"Kurita Y, Fujita Y, Sekino Y, et al. IgG4-related sclerosing cholangitis may be a risk factor for cancer. J Hepatobiliary Pancreat Sci. 2021;28(6):524\u201332.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"11","key":"4598_CR59","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00535-020-01714-7","volume":"55","author":"AH Ali","year":"2020","unstructured":"Ali AH, Bi Y, Machicado JD, et al. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience. J Gastroenterol. 2020;55(11):1087\u201397.","journal-title":"J Gastroenterol"},{"issue":"2","key":"4598_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2025","unstructured":"Diao X, Guo C, Jin Y, et al. Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun (Lond). 2025;45(2):178\u201397.","journal-title":"Cancer Commun (Lond)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04598-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:05:21Z","timestamp":1770649521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4598"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04598-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Peking Union Medical College Hospital Institutional Review Board and the ethical approval number was I-23PJ274. The requirement of informed consent to participate was waived by the Peking Union Medical College Hospital Institutional Review Board owing to the retrospective nature of the study. Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}